Funding for this research was provided by:
Bundesverband der Arzneimittel-Hersteller (n/a)
Received: 29 October 2018
Accepted: 5 June 2019
First Online: 20 June 2019
Ethics approval and consent to participate
: The University of Auckland Human Participants Ethics Committee (New Zealand) provided ethics approval (020041). Written informed consent was received from each participant. The Arbeitskreis Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland e.V. (Working Group of Medical Ethics Commissions in the Federal Republic of Germany e.V.) provided written confirmation that no additional German ethics committee approval was required for this study to be conducted in Germany (6 October 2017).
: Not applicable.
: The author has received travel and speaker funding from Bundesverband der Arzneimittel-Hersteller (BAH) a pharmaceutical industry organisation in Germany, and received funding from a pharmacy retail group, pharmaceutical companies and pharmacy organisations for reclassification consultancy and research outside of Germany.